Dextran sulfate as a leukocyte-endothelium adhesion molecule inhibitor of lung injury in pediatric open-heart surgery

Perfusion

Volumn 20, Issue 2, 2005, Pages 77-82

  Komai, Hiroyoshi ^a,b   Naito, Yasuaki ^a   Okamura, Yoshitaka ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Saiseikai Wakayama Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; DEXTRAN SULFATE; ELASTASE; PLACEBO;

ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INFUSION; ENZYME BLOOD LEVEL; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFANT; LEUKOCYTE COUNT; LUNG INJURY; MAJOR CLINICAL STUDY; OPEN HEART SURGERY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTICOAGULANTS; CELL ADHESION; CELL ADHESION MOLECULES; CHILD; CHILD, PRESCHOOL; DEXTRAN SULFATE; ENDOTHELIUM, VASCULAR; EXTRACORPOREAL CIRCULATION; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; INFANT; LEUKOCYTES; LUNG; MALE; POSTOPERATIVE PERIOD;

EID: 18844460714     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659105pf788oa     Document Type: Article

References (26)

1. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-47.
2. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass. N Eng J Med 1981; 304: 487-503.
3. Howard RJ, Crain C, Franzini DA, Hood I, Hugli TE. Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation. Arch Surg 1988; 123: 1496-501.
4. Komai H, Haworth SG. The effect of cardiopulmonary bypass on the lung. In Jonas R, Elliott MJ eds. Cardiopulmonary bypass in neonates, infants and young children. London: Butterworth Heinemann, 1994: 242-62.
5. Hattori R, Hamilton KK, Fugate RD, McEver RP, Sims PJ. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989; 264: 7768-71.
6. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1985; 91: 379-87.
7. Zimmerman GA, McIntyre TM, Mehra M, Prescott SM, Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol 1990; 110: 529-40.
8. DiScipio RG, Daffern PJ, Jagels MA, Broide DH, Sriramarao P. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J Immunol 1999; 162: 1127-36.
9. Guo R, Ward PA. Mediators and regulation of neutrophil accumulation in inflammatory response in lung: insights from the IgG immune complex model. Free Radic Biol Med 2002; 33: 303-10.
10. Skinner MP, Lucas CM, Burns GF, Chesterman CN, Berndt MC. GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem 1991; 266: 5371-74.
11. Cohen H, Tudhope GR. Dextran sulphate: use as an anticoagulant, and action in lowering serum cholesterol. Brit Med J 1956; 2: 1023-27.
12. Komai H, Yamamoto F, Yagihara T, Kawashima Y. Prevention of lung injury during open heart operations for congenital heart defects. Ann Thorac Surg 1994; 57: 134-40.
13. Komai H, Naito Y, Fujiwara K, Takagaki Y, Noguchi Y, Nishimura Y. The protective effect of a leucocyte removal filter on the lung in open-heart surgery for ventricular septal defect. Perfusion 1998; 13: 27-34.
14. Lefer DJ, Flynn DM, Buda AJ. Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion. Am J Physiol 1996; 270 (1 Part 2): H88-98.
15. x. Circ Res 1999; 84: 525-35.
16. Carden DL, Young JA, Granger DN. Pulmonary microvascular injury after intestinal ischemia-reperfusion: role of P-selectin. J Appl Physiol 1993; 75: 2529-34.
17. Kushimoto S, Okajima K, Uchiba M et al. Pulmonary vascular injury induced by hemorrhagic shock is mediated by P-selectin in rats. Thrombosis Research 1996, 82: 97-106.
18. Komai H, Haworth SG. Effect of cardiopulmonary bypass on the circulating level of soluble GMP-140. Ann Thorac Surg 1994; 58: 478-82.
19. Hayashi Y, Sawa Y, Nishimura M et al. P-selectin participates in cardiopulmonary bypass-induced inflammatory response in association with nitric oxide and peroxynitrite production. J Thorac Cardiovasc Surg 2000; 120: 558-65.
20. X oligosaccharide preserves cardiopulmonary and endothelial function after hypothermic circulatory arrest in lambs. J Thorac Cardiovasc Surg 2000; 120: 230-37.
21. Matsumiya A, Yamaguchi M, Nakano H, Takeda M, Kumada K. Dextran sulfate inhibits E-selectin-mediated neutrophil adhesion to endotoxin-activated vascular endothelial cells. Life Sci 1999; 64: PL9-17.
22. Unger G, Mist SH. Observation on the release of serum fibrinolysin by specific antigen, peptone and certain polysaccharides. J Exp Med 1949; 90: 39-51.
23. Nakajima K, Shirai K, Aoki M, Yasunaga K. Effect of dextran sulfate on platelet aggregation in rabbits. Act Haematol Jap 1978; 41: 803-809.
24. Fornasieri A, D'Amico G. Experimental IgA mesangial nephropathy: the role of antigen and antibody. Contrib Nephrol 1995; 111: 149-54.
25. Oehninger S, Acosta A, Hodgen GD. Antagonistic and agonistic properties of saccharide moieties in the hemizona assay. Fertil Steril 1990; 53: 143-49.
26. Sharar SR, Sasaki SS, Flaherty LC, Paulson JC, Harlan JM, Winn RK. P-selectin blockade does not impair leukocyte host defense against bacterial peritonitis and soft tissue infection in rabbits. J Immunol 1993; 151: 4982-88.